| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | LOTION, AUGMENTED / TOPICAL | 0.2 %w/w | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | | 187 mg | Exact identifier — unii candidate 39 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | SUSPENSION / ORAL | | 100 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, DELAYED RELEASE / ORAL | | 2313 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | | 278 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, EXTENDED RELEASE / ORAL | | 864 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 144 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | | 4441 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | | 64 mg | Exact identifier — unii candidate 39 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | LOZENGE / ORAL | | 50 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION/ DROPS / OPHTHALMIC | | 3 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | | 7 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | | 174 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | | 40 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SHAMPOO / TOPICAL | 3 %w/w | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | | 300 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | FILM / BUCCAL | 0.27 mg | | Exact identifier — unii candidate 20 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | | 1472 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | | 315 mg | Exact identifier — unii candidate 39 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | | 729 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CAPSULE, COATED PELLETS / ORAL | | 265 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | GRANULE, FOR SUSPENSION / ORAL | | 194 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | | 602 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, COATED / ORAL | 13.6 mg | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | | 18 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 18 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | | 520 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, CHEWABLE / ORAL | | 10 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | | 56 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET / ORAL | | 230 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | | 6 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | CAPSULE, DELAYED RELEASE / ORAL | | 150 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | | 349 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | JELLY / TOPICAL | NA | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING / ORAL | | 8 mg | Exact identifier — unii candidate 20 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | | 58 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | | 6 mg | Exact identifier — unii candidate 20 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | | 1190 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INHALANT / ORAL | NA | | Exact identifier — unii candidate 38 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | GEL / TRANSDERMAL | | 20 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, DELAYED RELEASE / ORAL | | 7 mg | Exact identifier — unii candidate 20 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | GRANULE, FOR SUSPENSION / ORAL | | 11 mg | Exact identifier — unii candidate 20 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYSTEM / TOPICAL | | 54 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | POWDER, FOR SUSPENSION / ORAL | | 200 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INSERT / VAGINAL | | 2282 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | LOTION / TOPICAL | | 10 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | | 582 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, ORALLY DISINTEGRATING / ORAL | | 366 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | FILM / BUCCAL | | 87 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | | Exact identifier — unii candidate 39 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | | 992 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | | 6184 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | | 104 mg | Exact identifier — unii candidate 39 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | | 202 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |